194 related articles for article (PubMed ID: 32319602)
41. The interferon response inhibits HIV particle production by induction of TRIM22.
Barr SD; Smiley JR; Bushman FD
PLoS Pathog; 2008 Feb; 4(2):e1000007. PubMed ID: 18389079
[TBL] [Abstract][Full Text] [Related]
42. Impact of TRIM5α and TRIM22 Genes Expression on the Clinical Course of Coronavirus Disease 2019.
Tavakoli R; Rahimi P; Hamidi-Fard M; Eybpoosh S; Doroud D; Sadeghi SA; Zaheri Birgani M; Aghasadeghi M; Fateh A
Arch Med Res; 2023 Feb; 54(2):105-112. PubMed ID: 36621405
[TBL] [Abstract][Full Text] [Related]
43. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
44. Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.
Reddi TS; Merkl PE; Lim SY; Letvin NL; Knipe DM
PLoS Pathog; 2021 Feb; 17(2):e1009281. PubMed ID: 33524065
[TBL] [Abstract][Full Text] [Related]
45. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
46. Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation.
Obad S; Olofsson T; Mechti N; Gullberg U; Drott K
J Interferon Cytokine Res; 2007 Oct; 27(10):857-64. PubMed ID: 17970695
[TBL] [Abstract][Full Text] [Related]
47. Upregulation of miRNA‑301a‑3p promotes tumor progression in gastric cancer by suppressing NKRF and activating NF‑κB signaling.
Xu X; Xia Y; Ma J; Li W; Niu N; Li X; Tao H; Xu J; He X
Int J Oncol; 2020 Aug; 57(2):522-532. PubMed ID: 32468020
[TBL] [Abstract][Full Text] [Related]
48. Ancient and recent adaptive evolution in the antiviral TRIM22 gene: identification of a single-nucleotide polymorphism that impacts TRIM22 function.
Kelly JN; Woods MW; Xhiku S; Barr SD
Hum Mutat; 2014 Sep; 35(9):1072-81. PubMed ID: 24863734
[TBL] [Abstract][Full Text] [Related]
49. The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase.
Petersson J; Lönnbro P; Herr AM; Mörgelin M; Gullberg U; Drott K
Exp Cell Res; 2010 Feb; 316(4):568-79. PubMed ID: 20006605
[TBL] [Abstract][Full Text] [Related]
50. BRG1 is indispensable for IFN-γ-induced TRIM22 expression, which is dependent on the recruitment of IRF-1.
Wang Y; Gao B; Xu W; Xiong S
Biochem Biophys Res Commun; 2011 Jul; 410(3):549-54. PubMed ID: 21683060
[TBL] [Abstract][Full Text] [Related]
51. TRIM9 overexpression promotes uterine leiomyoma cell proliferation and inhibits cell apoptosis via NF-κB signaling pathway.
Yang F; Liu H; Yu Y; Xu L
Life Sci; 2020 Sep; 257():118101. PubMed ID: 32679146
[TBL] [Abstract][Full Text] [Related]
52. Nuclear localization signal in TRIM22 is essential for inhibition of type 2 porcine reproductive and respiratory syndrome virus replication in MARC-145 cells.
Jing H; Tao R; Dong N; Cao S; Sun Y; Ke W; Li Y; Wang J; Zhang Y; Huang H; Dong W
Virus Genes; 2019 Oct; 55(5):660-672. PubMed ID: 31375995
[TBL] [Abstract][Full Text] [Related]
53. TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection.
Boswell MT; Yindom LM; Hameiri-Bowen D; McHugh G; Dauya E; Bandason T; Mujuru H; Esbjörnsson J; Ferrand RA; Rowland-Jones S
AIDS; 2021 Dec; 35(15):2445-2450. PubMed ID: 34870928
[TBL] [Abstract][Full Text] [Related]
54. microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.
Zhou H; Xu X; Xun Q; Yu D; Ling J; Guo F; Yan Y; Shi J; Hu Y
Oncol Rep; 2012 Mar; 27(3):807-12. PubMed ID: 22139444
[TBL] [Abstract][Full Text] [Related]
55. Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow.
Obad S; Olofsson T; Mechti N; Gullberg U; Drott K
Leuk Res; 2007 Jul; 31(7):995-1001. PubMed ID: 17257675
[TBL] [Abstract][Full Text] [Related]
56. TRIM22 induces cellular senescence by targeting PHLPP2 in hepatocellular carcinoma.
Kang D; Hwang HJ; Baek Y; Sung JY; Kim K; Park HJ; Ko YG; Kim YN; Lee JS
Cell Death Dis; 2024 Jan; 15(1):26. PubMed ID: 38199981
[TBL] [Abstract][Full Text] [Related]
57. Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines.
Turrini F; Saliu F; Forlani G; Das AT; Van Lint C; Accolla RS; Berkhout B; Poli G; Vicenzi E
Virus Res; 2019 Aug; 269():197631. PubMed ID: 31136823
[TBL] [Abstract][Full Text] [Related]
58. Forkhead box O1-mediated ubiquitination suppresses RIG-I-mediated antiviral immune responses.
Ma Z; Zhang W; Fan W; Wu Y; Zhang M; Xu J; Li W; Sun L; Liu W; Liu W
Int Immunopharmacol; 2021 Jan; 90():107152. PubMed ID: 33187908
[TBL] [Abstract][Full Text] [Related]
59. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
60. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
